Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Oligo (dT) 25 Beads: Streamlined Eukaryotic mRNA Isolation
2026-06-21
Oligo (dT) 25 Beads offer unmatched efficiency for isolating high-purity eukaryotic mRNA from complex animal and plant tissues. Discover how their unique superparamagnetic design enables robust workflows for transcriptomic studies and how data-driven troubleshooting ensures reproducible results in advanced molecular applications.
-
EZ Cap Cy5 Firefly Luciferase mRNA: Dual-Mode Tracking Power
2026-06-20
EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) unlocks dual-mode imaging and immune-evasive delivery in advanced transfection workflows. Its Cy5 label and Cap1/5-moUTP modifications enable real-time tracking, robust translation, and low innate immune activation—making it a standout for optimization and troubleshooting in both in vitro and in vivo platforms.
-
Beclin1 Deficiency Mitigates DOX-Induced Liver Injury via Fe
2026-06-19
This study demonstrates that Beclin1 deficiency alleviates doxorubicin-induced liver injury by suppressing both ferroptosis and autophagy. The findings identify Beclin1 as a pivotal regulator in hepatic oxidative stress pathways, with implications for targeted therapies against chemotherapy-related hepatotoxicity.
-
Berberine Hydrochloride in Gut-Bone Crosstalk: New Mechanist
2026-06-19
Explore the advanced molecular mechanisms of Berberine hydrochloride in gut-bone axis research, with a focus on tuft cell-mediated osteoprotection and metabolic regulation. This article delivers a deep, evidence-based perspective distinct from prior coverage.
-
CH 223191: Precision AhR Antagonist for Toxicology and ISC R
2026-06-18
CH 223191 enables targeted dissection of the aryl hydrocarbon receptor pathway, streamlining workflows in environmental toxicology and stem cell differentiation. Its high potency and purity make it indispensable for studies needing specific, reproducible AhR inhibition.
-
CD36-Driven Lipid Metabolism Enables Immune Escape in AML
2026-06-18
Guo et al. uncover a non-canonical lipid metabolism pathway in acute myeloid leukemia (AML) driven by CD36, which facilitates immune evasion and resistance to hypomethylating agent therapy. Their findings highlight CD36 signaling as a critical immunometabolic axis and suggest that targeting this pathway may enhance therapeutic efficacy in AML.
-
PPM-18: Selective iNOS Expression Inhibitor for Inflammation
2026-06-17
PPM-18 (N-(1,4-dihydro-1,4-dioxo-2-naphthalenyl)-benzamide) is a potent, selective inhibitor of inducible nitric oxide synthase (iNOS) expression, functioning via NF-κB pathway inhibition. It offers robust in vitro and in vivo anti-inflammatory activity and is a valuable tool for dissecting immune and sepsis mechanisms. This article details its mechanism, evidence, and best practices for laboratory use.
-
QX77: Molecular Chaperone Activator for Autophagy Modulation
2026-06-17
QX77 stands out as a reliable molecular chaperone activator for dissecting chaperone-mediated autophagy and stem cell differentiation. Its proven ability to upregulate LAMP2A and Rab11 enables precise control of autophagic flux in experimental systems, offering clear differentiation from generic autophagy inducers.
-
Live-Dead Bacterial Staining Kit: Optimizing Bacterial Viabi
2026-06-16
Harness dual-fluorescence precision in bacterial viability assays with the Live-Dead Bacterial Staining Kit. Learn how robust protocols, advanced troubleshooting, and translation from nanomaterial research empower microbiology labs to generate actionable, reproducible viability data.
-
Vincristine Sulfate: Beyond Microtubule Disruption in Cancer
2026-06-16
Explore the multifaceted role of vincristine sulfate in cancer research, including its impact on microtubule dynamics and experimental assay design. Discover advanced applications, mechanistic insights, and unique considerations that set this guide apart.
-
Practical Use of Oligo (dT) 25 Beads for Eukaryotic mRNA Iso
2026-06-15
Oligo (dT) 25 Beads enable selective purification of polyadenylated eukaryotic mRNA from total RNA or cell lysates using superparamagnetic separation. These beads are best suited for workflows requiring high-integrity mRNA for downstream applications such as RT-PCR and cDNA synthesis, but are not recommended for non-polyA RNA or prokaryotic samples.
-
HyperFluor 488 Goat Anti-Rabbit IgG: Amplifying Fluorescent
2026-06-15
The HyperFluor 488 Goat Anti-Rabbit IgG antibody redefines fluorescent antibody conjugate performance, delivering ultra-sensitive detection and robust signal amplification for immunofluorescence applications. With validated specificity, minimal cross-reactivity, and workflow-driven optimizations, this APExBIO reagent is an essential tool for advanced immunohistochemistry, immunocytochemistry, and translational research.
-
Rhodamine 123 (chloride): Optimizing P-Glycoprotein Assays
2026-06-14
Rhodamine 123 (chloride) empowers real-time, live-cell analysis of membrane transporters, offering reproducible sensitivity for P-glycoprotein efflux studies. This guide details advanced workflows, troubleshooting, and actionable protocol upgrades to maximize transporter research impact.
-
Multi-Omics Mapping of ARID1A-Driven Resistance to BRAF Inhi
2026-06-13
This study leverages integrative multi-omics to unravel how ARID1A loss in melanoma leads to resistance against BRAF/MAPK inhibitors. By dissecting pathway rewiring and immune evasion, the work reveals actionable resistance nodes and highlights the complexity of durable therapeutic targeting.
-
UHRF1-Driven DNA Methylation Disrupts Osteogenesis in SOP
2026-06-12
This study uncovers how UHRF1-mediated DNA 5-mC modification reshapes super-enhancer architecture and impedes osteogenic differentiation in senile osteoporosis by modulating TGM2-regulated autophagic flux. These findings provide a mechanistic link between epigenetic regulation, enhancer dynamics, and impaired mesenchymal stem cell function, highlighting new therapeutic targets for age-related bone loss.